Re: Surveillance or Metastasis-directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II Trial

Re: Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II Trial

The Journal of Urology ◽

10.1016/j.juro.2018.05.047 ◽

2018 ◽

Vol 200 (2) ◽

pp. 245-246

Author(s):

Samir S. Taneja

Keyword(s):

Prostate Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Cancer Recurrence ◽

Multicenter Phase ◽

Surveillance or metastasis-directed Therapy for OligoMetastatic Prostate cancer recurrence (STOMP): study protocol for a randomized phase II trial

BMC Cancer ◽

10.1186/1471-2407-14-671 ◽

2014 ◽

Vol 14 (1) ◽

Cited By ~ 65

Author(s):

Karel Decaestecker ◽

Gert De Meerleer ◽

Filip Ameye ◽

Valerie Fonteyne ◽

Bieke Lambert ◽

...

Keyword(s):

Prostate Cancer ◽

Phase Ii ◽

Study Protocol ◽

Phase Ii Trial ◽

Cancer Recurrence ◽

Randomized Phase Ii ◽

OLIGOPELVIS GETUG P07, a Multicenter Phase II Trial of Combined High-dose Salvage Radiotherapy and Hormone Therapy in Oligorecurrent Pelvic Node Relapses in Prostate Cancer

European Urology ◽

10.1016/j.eururo.2021.06.010 ◽

2021 ◽

Author(s):

Stéphane Supiot ◽

Loig Vaugier ◽

David Pasquier ◽

Xavier Buthaud ◽

Nicolas Magné ◽

...

Keyword(s):

Prostate Cancer ◽

Hormone Therapy ◽

Phase Ii ◽

Phase Ii Trial ◽

Salvage Radiotherapy ◽

High Dose ◽

Pelvic Node ◽

Multicenter Phase

A Phase II Study of [90Y] Yttrium-Capromab Pendetide in the Treatment of Men with Prostate Cancer Recurrence Following Radical Prostatectomy

Cancer Biotherapy & Radiopharmaceuticals ◽

10.1089/cbr.1999.14.99 ◽

1999 ◽

Vol 14 (2) ◽

pp. 99-111 ◽

Cited By ~ 36

Author(s):

Daniel Kahn ◽

J. Christopher Austin ◽

Robert T. Maguire ◽

Sara J. Miller ◽

Jack Gerstbrein ◽

...

Keyword(s):

Prostate Cancer ◽

Radical Prostatectomy ◽

Phase Ii ◽

Phase Ii Study ◽

Cancer Recurrence ◽

Prostate Cancer Recurrence

SP-0375: Surveillance or metastasis-directed Therapy for OligoMetastatic Prostate cancer recurrence

Radiotherapy and Oncology ◽

10.1016/s0167-8140(18)30685-6 ◽

2018 ◽

Vol 127 ◽

pp. S191-S192

Author(s):

P. Ost ◽

D. Reynders ◽

K. Decaestecker ◽

V. Fonteyne ◽

N. Lumen ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Recurrence ◽

EP-1360: Stereotactic body radiotherapy for oligometastatic prostate cancer recurrence after local treatment

Radiotherapy and Oncology ◽

10.1016/s0167-8140(17)31795-4 ◽

2017 ◽

Vol 123 ◽

pp. S729-S730

Author(s):

P.A. laurent ◽

E. Martin ◽

F. Cousin ◽

M. Quivrin ◽

F. Bidault ◽

...

Keyword(s):

Prostate Cancer ◽

Stereotactic Body Radiotherapy ◽

Local Treatment ◽

Cancer Recurrence ◽

Accelerated BEP for metastatic germ cell tumours: a multicenter phase II trial by the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP)

Annals of Oncology ◽

10.1093/annonc/mdt369 ◽

2014 ◽

Vol 25 (1) ◽

pp. 143-148 ◽

Cited By ~ 19

Author(s):

P.S. Grimison ◽

M.R. Stockler ◽

M. Chatfield ◽

D.B. Thomson ◽

V. Gebski ◽

...

Keyword(s):

Prostate Cancer ◽

New Zealand ◽

Germ Cell ◽

Phase Ii ◽

Phase Ii Trial ◽

Germ Cell Tumours ◽

Multicenter Phase ◽

Cancer Trials

Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Recurrence

American Journal of Clinical Oncology ◽

10.1097/coc.0000000000000635 ◽

2020 ◽

Vol 43 (2) ◽

pp. 73-81 ◽

Cited By ~ 2

Author(s):

Gustavo A. Viani ◽

Caio V. Arruda ◽

Ana C. Hamamura ◽

Alexandre C. Faustino ◽

Anielle Freitas Bendo Danelichen ◽

...

Keyword(s):

Prostate Cancer ◽

Stereotactic Body Radiotherapy ◽

Cancer Recurrence ◽

Multicenter Phase II Trial of the Heat Shock Protein 90 Inhibitor, Retaspimycin Hydrochloride (IPI-504), in Patients With Castration-resistant Prostate Cancer

Urology ◽

10.1016/j.urology.2011.04.041 ◽

2011 ◽

Vol 78 (3) ◽

pp. 626-630 ◽

Cited By ~ 47

Author(s):

William K. Oh ◽

Matthew D. Galsky ◽

Walter M. Stadler ◽

Sandy Srinivas ◽

Franklin Chu ◽

...

Keyword(s):

Prostate Cancer ◽

Heat Shock ◽

Heat Shock Protein ◽

Phase Ii ◽

Phase Ii Trial ◽

Heat Shock Protein 90 ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant ◽

Multicenter Phase

Absorbable hydrogel spacer use in men undergoing prostate cancer radiotherapy: 12 month toxicity and proctoscopy results of a prospective multicenter phase II trial

Radiation Oncology ◽

10.1186/1748-717x-9-96 ◽

2014 ◽

Vol 9 (1) ◽

Cited By ~ 45

Author(s):

Matthias Uhl ◽

Klaus Herfarth ◽

Michael J Eble ◽

Michael Pinkawa ◽

Baukelien van Triest ◽

...

Keyword(s):

Prostate Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Cancer Radiotherapy ◽

Multicenter Phase ◽

Prostate Cancer Radiotherapy